RecruitingPhase 1NCT06860594
Oncology
Diffuse hemispheric glioma-H3 G34-mutant
5
studies recruiting now
as of 7 Sept 2026
10
studies registered in total
as of 7 Sept 2026
6
countries with a recruiting site
as of 7 Sept 2026
31 Oct 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT06914479
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
RecruitingPhase 1NCT07223034
A Study of 177Lu-PSMA-617 in People With Gliomas
RecruitingPhase 2NCT05843253
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 1 / Phase 2NCT06630260
5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Diffuse hemispheric glioma-H3 G34-mutant studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Diffuse hemispheric glioma-H3 G34-mutant study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Diffuse hemispheric glioma-H3 G34-mutant
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).